Awards
- Lead Principal Investigator and Outstanding Research Team Awards, NIHR NW London CRN, 2019
- NIHR Lead Investigator Award Commercial Trials, NIHR, 2016
- Imperial College President & Rector’s Award for Research Supervision 2013, Imperial College London, 2013
- Imperial College President & Rector’s Gold Medal 2012, Imperial College London, 2012
- Best Therapeutic Innovation (Respiratory) 2011, Medical Futures Innovation Award, 2011
- MRC Translational Research Award 2011, Medical Futures Innovation Award, 2011
- Imperial College Outstanding Research Team 2015, Imperial College London
External Positions
- Member, Trial steering committee: Using medical-detection dogs to identify people with SARS-CoV-2. Phase I. Proof-of-concept studies, 2020
- Deputy president, European CF Society, European CF Society, 2020
- President, ECFS Global Conference, European CF Society, 2019
- Chair, R-TRC CF National Strategic Research Group, NIHR, 2019
- member/ Imperial representative, Steering Committee, NIHR, 2019
- Clinical Professor of Paediatrics with special focus on Childhood Asthma, Invited external expert, Professorial appointment committee, University of Copenhagen, 2018
- Chair, Clinical Trials Accelerator Platform (CTAP) Research & Scientific Oversight Committee, Cystic Fibrosis Trust, 2018
- Member, European CF Society Board, European CF Society, 2018
- Fellow, European Respiratory Society, European Respiratory Society, 2018
- Lead, UK Clinical Trials Accelerator Platform London Network, Cystic Fibrosis Trust, 2018
- Professor of Clinical Microbiology, Invited external expert, Professorial appointment committee, University of Copenhagen, 2017
- Member, Respiratory Research Committee, Royal Brompton Hospital, 2017
- Chair, Data Safety Monitoring Committee: HTA-funded ProteKt trial, HTA-funded ProteKt trial, 2016 - 2018
- Member, ECFS Annual Global Conference: Organising Board, European CF Society, 2016 - 2019
- Member, Clinical Research Oversight Committee, Royal Brompton Hospital, 2015
- Member, Paediatric Lung Conditions Research Advisory Board, British Lung Foundation, 2015
- Member, ECFS Annual Global Conference: Scientific Committee, European CF Society, 2014 - 2014
- Chair, Research Committee, British Paediatric Respiratory Society, 2014
- Paediatric Lead, Science & Research Committee, British Thoracic Society, 2014
- Paediatric Lead, Training & Education Committee, British Thoracic Society, 2014 - 2019
- Vice-chair, Strategic Advisory Board, Cystic Fibrosis Trust, 2013
- Member, ECFS Annual Global Conference: Scientific Committee, European CF Society, 2012 - 2015
- Member, NIHR Clinical Research Network, Paediatric Respiratory and Cystic Fibrosis Clinical Studies Group, NIHR, 2010
- Member, Research Ethics Committee, Royal Brompton Hospital, 2007 - 2010
- Member and Clinical Lead, Strategy Group UK CF Gene Therapy Consortium, Royal Brompton Hospital, 2000
- Vice-chair, CF Trust Strategy Implementation grant review Board, Cystic Fibrosis Trust
- Member, Diagnostic Working Group, European CF Society
- Director, European Lung Clearance Index Core Facility, European CF Society
- Vice-chair, Grant Review Board: CF Trust Strategy Implementation Board, Cystic Fibrosis Trust
- Member, Grant Review Board: Gilead Sciences Research Scholars Program in Cystic Fibrosis, Gilead Sciences
- Member, Grant Review Board: Vertex Innovations Awards, Vertex Pharmaceuticals
- Member, Paediatric & CF working groups, European Respiratory Society
- Member, Research Consultation Committee, Royal College of Paediatrics & Child Health
- Respiratory Translational Research Collaborative (TRC), NIHR
- Fellow, Royal College of Paediatrics & Child Health, Royal College of Paediatrics & Child Health
- Principal Investigator, Site Lead Clinical Trials Network, European CF Society
- Member, Standardisation Committee for Outcome measures, European CF Society
- Lead, Strategic Task Force to speed access to new therapies, European CF Society
Industrial Connections
- Algipharma, Clinical advisor in new treatments for CF
- Boehringer Ingelheim, Clinical advisor in new treatments for CF
- Chiesi, Clinical advisor in new treatments for CF
- Eloxx, Clinical advisor in new treatments for CF
- Enterprise Therapeutics, Clinical advisor in new treatments for CF
- Ionis, Clinical advisor in new treatments for CF
- Novartis, Clinical advisor in new treatments for CF
- PTC Therapeutics, Clinical advisor in new treatments for CF
- ProQR, Clinical advisor in new treatments for CF
- Proteostasis, Clinical advisor in new treatments for CF
- Pulmocide, Clinical advisor in new treatments for CF
- Vertex Pharmaceuticals, Clinical advisor in new treatments for CF
Editorial Boards
- Journal of Cystic Fibrosis, Deputy Editor, 2020
- Thorax, Associate editor, 2014 - 2020
- Pediatric Allergy, Immunology and Pulmonology, Editorial Board, 2010 - 2013
- Paediatric Respiratory Reviews, Series Editor: New Biology of the Airways, 2002